IL15 and neoplasm: In nonclinical models, IL15 co-expression in CAR T cells significantly improves their ability to expand, persist, and induce complete tumor regression3,4,14; however, it is unknown how IL15 impacts CAR T cell antitumor activity and safety in humans.